About Magnolia Bark
Magnolia bark contains honokiol and magnolol, bioactive compounds that modulate GABA-A receptors. Preclinical evidence is promising but human RCTs for sleep are very limited. Emerging ingredient in sleep formulations. No established RDA/UL.
What Magnolia Bark supports
- May promote relaxation via GABA-A modulation
- Emerging evidence for sleep support, limited human data
How much Magnolia Bark to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
200–500
mg
Standardized for honokiol/magnolol content; limited clinical dosing data.
Clinical evidence
Limited clinical evidence. Promising preclinical GABA-A receptor data, but very limited human clinical trials for sleep
Examine.com